Ciclopirox enhances pancreatic islet health by modulating the unfolded protein response in diabetes
- 228 Downloads
Pancreatic dysfunction during diabetes is linked to the induction of endoplasmic reticulum (ER) stress on pancreatic beta (β) cells. Our laboratory recently discovered that p21 protects from diabetes by modifying the outcome of ER stress response. In the present study, we explored the antidiabetic activity of ciclopirox (CPX), an iron chelator and recently described activator of p21 expression. The effects of CPX in beta cell survival and function were assessed in cultured islets in vitro as well as in diabetic mice in vivo. The consequences of CPX in high glucose-induced insulin release and reactive oxygen species (ROS) production were also evaluated. Islet survival assays confirmed the significance of p21 in the regulation of glucotoxicity and suggested that CPX counteracts glucotoxicity in a manner that depends on p21. In vivo, administration of CPX in wild-type (WT) diabetic mice restored glucose homeostasis. In WT-cultured islets, CPX suppressed the expression of ER stress markers BiP, GRP94, and CHOP and reduced the levels of ROS during culture at high glucose. This reduction of ER stress may be associated with the ability of CPX to inhibit insulin release. Iron citrate stimulated insulin release, which was inhibited by CPX that functions as an iron chelator. It is conceivable that inhibition of insulin production constrains ER stress in islets promoting their survival and thus protecting from diabetes in vivo. This unfolded protein response (UPR)-antagonizing activity of CPX suggests application for the management not only of diabetes but also of other conditions related to ER stress.
KeywordsUnfolded protein response Glucotoxicity Glucose Chaperone Beta cells
This study was supported by grant RAG051976A from NIH/NIA.
Compliance with ethical standards
Animal care and experiments were carried out in accordance with the guidelines of the Animal Facilities by the Athens University Medical School Ethics Committee in agreement with the European Union (approval no. 7924 /12/12/2014).
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Erion KA, Ferrante T, Corkey B, Deeney J (2013) Iron stimulates insulin secretion in clonal pancreatic β-cells and dissociated rat islets. FASEB J 27:1010.13Google Scholar
- 11.Linden T, Katschinski DM, Eckhardt K, Scheid A, Pagel H, Wenger RH (2003) The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis., The FASEB Journal : Official Publication of the Federation of American Societies for. Exp Biol 17:761–763Google Scholar
- 24.Pizarro-Delgado J, Deeney JT, Martín-del-Río R, Corkey BE, Tamarit-Rodriguez J (2015) KCl-permeabilized pancreatic islets: an experimental model to explore the messenger role of ATP in the mechanism of insulin secretion. PLoS One 10:e0140096. doi: 10.1371/journal.pone.0140096 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Porter DC, Farmaki E, Altilia S, Schools GP, West DK, Chen M, Chang BD, Puzyrev AT, Lim CU, Rokow-Kittell R, Friedhoff LT, Papavassiliou AG, Kalurupalle S, Hurteau G, Shi J, Baran PS, Gyorffy B, Wentland MP, Broude EV, Kiaris H, Roninson IB (2012) Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A 109:13799–13804CrossRefPubMedPubMedCentralGoogle Scholar